Search

everythinglearnresearchcommunity

for

Search:↓

Povidone-iodine nail solution effectively treats nail infections caused by chemotherapy.

Chemotherapy patients don't all lose their hair due to factors like hair growth rates, age, genetics, and the type of drugs used.

Some breast cancer chemotherapy can cause permanent hair loss.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

Ki-67 levels do not predict treatment response in triple-negative breast cancer.

Kang'ai injection with FLO chemotherapy improves effectiveness and quality of life in advanced gastric cancer patients.

Some side effects of breast cancer chemotherapy last longer than others, and patient feedback can help improve care.

CHOP chemotherapy for non-Hodgkin's lymphoma commonly causes hair loss, fatigue, taste changes, and nausea.

The Li-Pa/Ca and Do/Ca chemotherapy regimens for serous ovarian cancer showed better short-term and long-term results than the Pa/Ca regimen.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

Alopecia mucinosa on the face can be linked to mycosis fungoides, a type of lymphoma.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Scalp cooling helps prevent hair loss during chemotherapy, and minoxidil aids regrowth.

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

Chemotherapy causes hair loss, nausea, fatigue, and blood issues, but counseling can help manage these effects.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Non-myeloablative stem cell transplants are a promising, less toxic option for older or weaker patients, with fewer side effects and good outcomes.

Docetaxel chemotherapy causes more long-term hair loss and dissatisfaction than paclitaxel.

Some hair loss from medication may reverse after stopping the drug, but treatment options are limited and ongoing research is needed.

Patients often experience long-lasting changes to their hair after stem cell transplants.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

Taxane-based chemotherapy causes more hair loss and skin changes in Asian breast cancer patients.

Hodgkin's lymphoma can show up as hair loss.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Chemotherapy with docetaxel and cisplatin can cause severe low potassium, requiring careful monitoring and treatment.

Two cycles of ABVD chemotherapy followed by 20 Gy radiotherapy is the new standard for early-stage Hodgkin lymphoma due to lower toxicity and similar effectiveness.

About 22% of cancer patients had skin-related side effects from chemotherapy, but these were usually not severe enough to halt treatment.